# Survivin as Predictive Biomarker for RA

> **NCT03444623** · — · UNKNOWN · sponsor: **Vastra Gotaland Region** · enrollment: 6000 (estimated)

## Conditions studied

- Rheumatoid Arthritis
- Arthralgia
- Joint Pain

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03444623
- **Lead sponsor:** Vastra Gotaland Region
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-06
- **Primary completion:** 2023-06
- **Final completion:** 2023-12
- **Target enrollment:** 6000 (ESTIMATED)
- **Last updated:** 2022-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03444623

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03444623, "Survivin as Predictive Biomarker for RA". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03444623. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*